Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

215

Base Year:

2024

Jan - 2025

Format:

Report Code:

VMR-3964

Segments Covered

By Product Consumables, Equipment
By Technology Immunoassays, Chromatography-MS, Other Technologies
By Drug Class Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs
By Therapeutic Area Neurological Disorders, Cardiology, Infectious Diseases, Oncology, Other Therapeutic Areas
By Specimen Blood, Saliva, Other Samples
By End User Hospital Laboratories, Commercial & Private Laboratories, Other End Users
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4099 USD

Multi User License

$ 5250 USD

Enterprise License

$ 6400 USD

Snapshot

Base Year:	2024
Forecast Years:	2025 - 2035
Historical Years:	2019 - 2023
Revenue 2024:	USD 2.5 Billion
Revenue 2035:	USD 6.04 Billion
Revenue CAGR (2025 - 2035):	8.35%
Fastest Growing Region (2025 - 2035)	Asia Pacific
Largest Region (2024):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Global Therapeutic Drug Monitoring Market, 2016 - 2028 (USD Million)
3. Global Therapeutic Drug Monitoring Market - by Product
  1. By Consumables
  2. By Equipment
4. Global Therapeutic Drug Monitoring Market - by Technology
  1. By Immunoassays
  2. By Chromatography-MS
  3. By Other Technologies
5. Global Therapeutic Drug Monitoring Market - by Drug Class
  1. By Antiepileptic Drugs
  2. By Antiarrhythmic Drugs
  3. By Immunosuppressant Drugs
  4. By Antibiotic Drugs
  5. By Bronchodilator Drugs
  6. By Psychoactive Drugs
  7. By Other Drugs
6. Global Therapeutic Drug Monitoring Market - by Therapeutic Area
  1. By Neurological Disorders
  2. By Cardiology
  3. By Infectious Diseases
  4. By Oncology
  5. By Other Therapeutic Areas
7. Global Therapeutic Drug Monitoring Market - by Specimen
  1. By Blood
  2. By Saliva
  3. By Other Samples
8. Global Therapeutic Drug Monitoring Market - by End User
  1. By Hospital Laboratories
  2. By Commercial & Private Laboratories
  3. By Other End Users
9. Global Therapeutic Drug Monitoring Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
10. Market comparative analysis
North America Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. North America Therapeutic Drug Monitoring Market, 2016 - 2028 (USD Million)
3. North America Therapeutic Drug Monitoring Market, by Product
  1. By Consumables
  2. By Equipment
4. North America Therapeutic Drug Monitoring Market, by Technology
  1. By Immunoassays
  2. By Chromatography-MS
  3. By Other Technologies
5. North America Therapeutic Drug Monitoring Market, by Drug Class
  1. By Antiepileptic Drugs
  2. By Antiarrhythmic Drugs
  3. By Immunosuppressant Drugs
  4. By Antibiotic Drugs
  5. By Bronchodilator Drugs
  6. By Psychoactive Drugs
  7. By Other Drugs
6. North America Therapeutic Drug Monitoring Market, by Therapeutic Area
  1. By Neurological Disorders
  2. By Cardiology
  3. By Infectious Diseases
  4. By Oncology
  5. By Other Therapeutic Areas
7. North America Therapeutic Drug Monitoring Market, by Specimen
  1. By Blood
  2. By Saliva
  3. By Other Samples
8. North America Therapeutic Drug Monitoring Market, by End User
  1. By Hospital Laboratories
  2. By Commercial & Private Laboratories
  3. By Other End Users
9. North America Therapeutic Drug Monitoring Market, by Country
  1. U.S.
    1. U.S. Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. U.S. Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. U.S. Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. U.S. Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. U.S. Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. U.S. Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  2. Canada
    1. Canada Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Canada Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Canada Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Canada Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Canada Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Canada Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  3. Mexico
    1. Mexico Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Mexico Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Mexico Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Mexico Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Mexico Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Mexico Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
Europe Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Europe Therapeutic Drug Monitoring Market, 2016 - 2028 (USD Million)
3. Europe Therapeutic Drug Monitoring Market, by Product
  1. By Consumables
  2. By Equipment
4. Europe Therapeutic Drug Monitoring Market, by Technology
  1. By Immunoassays
  2. By Chromatography-MS
  3. By Other Technologies
5. Europe Therapeutic Drug Monitoring Market, by Drug Class
  1. By Antiepileptic Drugs
  2. By Antiarrhythmic Drugs
  3. By Immunosuppressant Drugs
  4. By Antibiotic Drugs
  5. By Bronchodilator Drugs
  6. By Psychoactive Drugs
  7. By Other Drugs
6. Europe Therapeutic Drug Monitoring Market, by Therapeutic Area
  1. By Neurological Disorders
  2. By Cardiology
  3. By Infectious Diseases
  4. By Oncology
  5. By Other Therapeutic Areas
7. Europe Therapeutic Drug Monitoring Market, by Specimen
  1. By Blood
  2. By Saliva
  3. By Other Samples
8. Europe Therapeutic Drug Monitoring Market, by End User
  1. By Hospital Laboratories
  2. By Commercial & Private Laboratories
  3. By Other End Users
9. Europe Therapeutic Drug Monitoring Market, by Country
  1. Germany
    1. Germany Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Germany Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Germany Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Germany Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Germany Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Germany Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  2. UK
    1. UK Market, By Product
      1. By Consumables
      2. By Equipment
    2. UK Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. UK Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. UK Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. UK Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. UK Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  3. France
    1. France Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. France Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. France Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. France Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. France Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. France Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  4. Spain
    1. Spain Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Spain Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Spain Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Spain Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Spain Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Spain Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  5. Italy
    1. Italy Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Italy Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Italy Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Italy Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Italy Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Italy Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  6. BENELUX
    1. BENELUX Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. BENELUX Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. BENELUX Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. BENELUX Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. BENELUX Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. BENELUX Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  7. Rest of Europe
    1. Rest Of Europe Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Rest Of Europe Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Rest Of Europe Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Rest Of Europe Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Rest Of Europe Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Rest Of Europe Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
Asia Pacific Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Asia Pacific Therapeutic Drug Monitoring Market, 2016 - 2028 (USD Million)
3. Asia Pacific Therapeutic Drug Monitoring Market, by Product
  1. By Consumables
  2. By Equipment
4. Asia Pacific Therapeutic Drug Monitoring Market, by Technology
  1. By Immunoassays
  2. By Chromatography-MS
  3. By Other Technologies
5. Asia Pacific Therapeutic Drug Monitoring Market, by Drug Class
  1. By Antiepileptic Drugs
  2. By Antiarrhythmic Drugs
  3. By Immunosuppressant Drugs
  4. By Antibiotic Drugs
  5. By Bronchodilator Drugs
  6. By Psychoactive Drugs
  7. By Other Drugs
6. Asia Pacific Therapeutic Drug Monitoring Market, by Therapeutic Area
  1. By Neurological Disorders
  2. By Cardiology
  3. By Infectious Diseases
  4. By Oncology
  5. By Other Therapeutic Areas
7. Asia Pacific Therapeutic Drug Monitoring Market, by Specimen
  1. By Blood
  2. By Saliva
  3. By Other Samples
8. Asia Pacific Therapeutic Drug Monitoring Market, by End User
  1. By Hospital Laboratories
  2. By Commercial & Private Laboratories
  3. By Other End Users
9. Asia Pacific Therapeutic Drug Monitoring Market, by Country
  1. China
    1. China Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. China Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. China Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. China Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. China Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. China Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  2. Japan
    1. Japan Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Japan Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Japan Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Japan Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Japan Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Japan Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  3. India
    1. India Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. India Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. India Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. India Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. India Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. India Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  4. South Korea
    1. South Korea Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. South Korea Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. South Korea Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. South Korea Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. South Korea Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. South Korea Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  5. South East Asia
    1. South East Asia Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. South East Asia Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. South East Asia Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. South East Asia Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. South East Asia Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. South East Asia Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Rest of Asia Pacific Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Rest of Asia Pacific Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Rest of Asia Pacific Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Rest of Asia Pacific Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Rest of Asia Pacific Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
Latin America Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Latin America Therapeutic Drug Monitoring Market, 2016 - 2028 (USD Million)
3. Latin America Therapeutic Drug Monitoring Market, by Product
  1. By Consumables
  2. By Equipment
4. Latin America Therapeutic Drug Monitoring Market, by Technology
  1. By Immunoassays
  2. By Chromatography-MS
  3. By Other Technologies
5. Latin America Therapeutic Drug Monitoring Market, by Drug Class
  1. By Antiepileptic Drugs
  2. By Antiarrhythmic Drugs
  3. By Immunosuppressant Drugs
  4. By Antibiotic Drugs
  5. By Bronchodilator Drugs
  6. By Psychoactive Drugs
  7. By Other Drugs
6. Latin America Therapeutic Drug Monitoring Market, by Therapeutic Area
  1. By Neurological Disorders
  2. By Cardiology
  3. By Infectious Diseases
  4. By Oncology
  5. By Other Therapeutic Areas
7. Latin America Therapeutic Drug Monitoring Market, by Specimen
  1. By Blood
  2. By Saliva
  3. By Other Samples
8. Latin America Therapeutic Drug Monitoring Market, by End User
  1. By Hospital Laboratories
  2. By Commercial & Private Laboratories
  3. By Other End Users
9. Latin America Therapeutic Drug Monitoring Market, by Country
  1. Brazil
    1. Brazil Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Brazil Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Brazil Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Brazil Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Brazil Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Brazil Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  2. Argentina
    1. Argentina Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Argentina Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Argentina Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Argentina Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Argentina Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Argentina Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  3. Rest of Latin America
    1. Rest of Latin America Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Rest of Latin America Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Rest of Latin America Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Rest of Latin America Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Rest of Latin America Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Rest of Latin America Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
Middle East & Africa Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Middle East & Africa Therapeutic Drug Monitoring Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Therapeutic Drug Monitoring Market, by Product
  1. By Consumables
  2. By Equipment
4. Middle East & Africa Therapeutic Drug Monitoring Market, by Technology
  1. By Immunoassays
  2. By Chromatography-MS
  3. By Other Technologies
5. Middle East & Africa Therapeutic Drug Monitoring Market, by Drug Class
  1. By Antiepileptic Drugs
  2. By Antiarrhythmic Drugs
  3. By Immunosuppressant Drugs
  4. By Antibiotic Drugs
  5. By Bronchodilator Drugs
  6. By Psychoactive Drugs
  7. By Other Drugs
6. Middle East & Africa Therapeutic Drug Monitoring Market, by Therapeutic Area
  1. By Neurological Disorders
  2. By Cardiology
  3. By Infectious Diseases
  4. By Oncology
  5. By Other Therapeutic Areas
7. Middle East & Africa Therapeutic Drug Monitoring Market, by Specimen
  1. By Blood
  2. By Saliva
  3. By Other Samples
8. Middle East & Africa Therapeutic Drug Monitoring Market, by End User
  1. By Hospital Laboratories
  2. By Commercial & Private Laboratories
  3. By Other End Users
9. Middle East & Africa Therapeutic Drug Monitoring Market, by Country
  1. GCC Countries
    1. GCC Countries Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. GCC Countries Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. GCC Countries Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. GCC Countries Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. GCC Countries Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. GCC Countries Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  2. South Africa
    1. South Africa Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. South Africa Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. South Africa Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. South Africa Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. South Africa Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. South Africa Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Therapeutic Drug Monitoring Market, By Product
      1. By Consumables
      2. By Equipment
    2. Rest of Middle East & Africa Therapeutic Drug Monitoring Market, By Technology
      1. By Immunoassays
      2. By Chromatography-MS
      3. By Other Technologies
    3. Rest of Middle East & Africa Therapeutic Drug Monitoring Market, By Drug Class
      1. By Antiepileptic Drugs
      2. By Antiarrhythmic Drugs
      3. By Immunosuppressant Drugs
      4. By Antibiotic Drugs
      5. By Bronchodilator Drugs
      6. By Psychoactive Drugs
      7. By Other Drugs
    4. Rest of Middle East & Africa Therapeutic Drug Monitoring Market, By Therapeutic Area
      1. By Neurological Disorders
      2. By Cardiology
      3. By Infectious Diseases
      4. By Oncology
      5. By Other Therapeutic Areas
    5. Rest of Middle East & Africa Therapeutic Drug Monitoring Market, By Specimen
      1. By Blood
      2. By Saliva
      3. By Other Samples
    6. Rest of Middle East & Africa Therapeutic Drug Monitoring Market, By End User
      1. By Hospital Laboratories
      2. By Commercial & Private Laboratories
      3. By Other End Users
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Thermo Fisher Scientific Inc.
2. Biomerieux SA
3. Abbott Laboratories
4. SEKISUI CHEMICAL CO. Ltd.
5. Danaher Corporation
6. F. Hoffmann-La Roche Ltd.
7. Siemens AG
8. Chromsystems Instruments & Chemicals GmbH
9. Exagen Inc.
10. Bio-Rad Laboratories Inc.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 17-Jan-2025

Therapeutic Drug Monitoring Market to Reach USD 6.04 Billion by 2035

FAQ

Frequently Asked Question

What is the global demand for Therapeutic Drug Monitoring in terms of revenue?

The global Therapeutic Drug Monitoring valued at USD 2.5 Billion in 2024 and is expected to reach USD 6.04 Billion in 2035 growing at a CAGR of 8.35%.

Which are the prominent players in the market?

The prominent players in the market are Thermo Fisher Scientific Inc., Biomerieux SA, Abbott Laboratories, SEKISUI CHEMICAL CO., LTD., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Chromsystems Instruments & Chemicals GmbH, Exagen Inc., Bio-Rad Laboratories, Inc..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 8.35% between 2025 and 2035.

What are the driving factors fueling the growth of the market.

The driving factors of the Therapeutic Drug Monitoring include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Therapeutic Drug Monitoring in 2024.

Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Therapeutic Drug Monitoring in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Therapeutic Drug Monitoring in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Therapeutic Drug Monitoring Market

Vantage Point Interactive Dashboard